002262 Jiangsu Nhwa Pharmaceutical
- 24.36
- -0.01-0.04%
Jiangsu Nhwa Pharmaceutical News
Jiangsu Nhwa Pharmaceutical: 2023 Annual Equity Distribution Implementation Notice
Jiangsu Nhwa Pharmaceutical: Notice on Obtaining a Notice of Approval for Supplementary Applications for Alfentanyl Hydrochloride Injection Drugs
Enhua Pharmaceutical: 002262 Enhua Pharmaceutical Investor Relations Management Information 20240425
Enhua Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Enhua Pharmaceutical: Legal Opinion of the 2023 Annual General Meeting of Shareholders of Jiangsu Enhua Pharmaceutical Co., Ltd.
Enhua Pharmaceutical: Announcement of Supervisory Board Resolutions
Enhua Pharmaceutical: Report for the first quarter of 2024
Enhua Pharmaceutical: Announcement of Board Resolutions
Enhua Pharmaceutical: Implementation Rules of the Special Committee of the Board of Directors (revised by the 10th meeting of the 6th Board of Directors of the Company on April 19, 2024)
Enhua Pharmaceutical: Prompt Announcement on Convening the 2023 Annual General Meeting of Shareholders
Enhua Pharmaceutical: Announcement on the actual controller's renewal of the concerted action agreement
Enhua Pharmaceutical: 002262 Enhua Pharmaceutical Investor Relations Management Information 20240409
Enhua Pharmaceutical: Announcement on NH103 Obtaining the “Drug Clinical Trial Approval Notice”
Enhua Pharmaceutical: 2023 Supervisory Board Report
Enhua Pharmaceutical: 2023 Annual Audit Report
Enhua Pharmaceutical: 2023 Independent Director Debriefing Report (Wang Guangji)
Enhua Pharmaceutical: 2023 Independent Director Debriefing Report (Li Yulan)
Enhua Pharmaceutical: 2023 Annual Report Summary
Enhua Pharmaceutical: Working System for Independent Directors (Revised Draft)
Enhua Pharmaceutical: Special explanation of the company's cumulative and current external guarantees by independent directors
Analysis
Price Target
No Data
